News releases - Merck.com
Oct 28, 2024 · Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers. October 23, 2024. CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older. October 19, 2024.
Merck Announces Third-Quarter 2024 Financial Results
Oct 31, 2024 · RAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2024. “Our third-quarter results were strong, as we continue to make progress heading into 2025 and beyond," said Robert M. Davis, chairman and chief executive officer, Merck.
KOSELUGO® (selumetinib) Showed Significant and Clinically ... - Merck
1 day ago · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject ...
News & Stories - Merck
Oct 9, 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Merck Enters Two Strategic Collaborations to Strengthen AI …
Sep 20, 2023 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
FDA approves Merck's drug for rare, deadly lung condition
Mar 26, 2024 · The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
Merck and AstraZeneca announce results of Koselugo in …
1 day ago · AstraZeneca and Merck are jointly developing and commercializing Koselugo globally. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Merck’s Covid Pill Is Authorized for High-Risk Adults - The New …
Dec 23, 2021 · Merck is expected to fulfill the federal government’s full order of enough pills for 3.1 million people, at a cost of about $700 a person, by the end of January. Pfizer is expected to provide...
Merck Launches First Ever AI Solution to Integrate Drug Discovery …
Dec 5, 2023 · MRK. Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies. Virtually screens compounds from a universe of >60 billion...
Merck KGaA's Cell-Tumor Drug Gets Positive Results in
1 day ago · By Helena Smolak. Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed ...